You must log in to view this page.

Protalix BioTherapeutics Inc. – Ownership Summary

NYSE American: PLX
Share price (5/29/26): $2.11
Market cap (5/29/26): $170 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Mamlok Gilad »

3/A

12/34/56

Bashan Dror »

12/34/56

≥5% Ownership

MAK Capital Fund LP »

SCHEDULE 13G/A

12/34/56

SCHEDULE 13G

12/34/56

Whitebox Advisors LLC »

SC 13G/A

12/34/56

SC 13G

12/34/56

Protalix BioTherapeutics Inc. – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Mamlok Gilad »

Bashan Dror »

≥5% Ownership

MAK Capital Fund LP »

Whitebox Advisors LLC »

Protalix BioTherapeutics Inc. – Ownership Summary